Maharashtra’s FDA commissioner, Tukaram Mundhe, urges the Union government to intervene after an IV set priced at Rs 11 is reportedly sold for Rs 325. He describes the increase as “irrational and unjustified” and calls for action to address what he frames as unreasonable pricing of commonly used hospital consumables.
Mundhe’s request is directed at reviewing pricing practices affecting essential medical supplies. The reported example highlights a sharp markup between the baseline cost and the price paid in the market. Different outlets focus on the same core claim: a significant increase in the cost of an item widely used in healthcare, and the commissioner’s appeal for the Centre to reassess and regulate the pricing of such consumables.
The coverage centres on the commissioner’s characterization of the hike and his appeal for government oversight, without detailing any immediate enforcement steps or final pricing decisions at the time of reporting.
